Showing 18,561 - 18,580 results of 46,434 for search '(( 5 ((wt decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.16s Refine Results
  1. 18561
  2. 18562
  3. 18563
  4. 18564
  5. 18565
  6. 18566
  7. 18567
  8. 18568
  9. 18569
  10. 18570

    Adipose tissue depot volume relationships with spinal trabecular bone mineral density in African Americans with diabetes by Gary C. Chan (4794924)

    Published 2018
    “…Over 5.3 ± 1.4 years, mean vBMD decreased in thoracic/lumbar spine, while mean adipose tissue volumes increased in SAT, IMAT, and PAT, but not VAT depots. …”
  11. 18571

    Differential requirements of NMDAR and VDCC for Aβ-induced declustering of Homer1b and Shank1. by Francesco Roselli (211670)

    Published 2009
    “…NMDA alone significantly reduced Homer (75.1±8.8%, p<0.05) and a further decrease was observed after NMDA+Aβ cotreatment (50.2±5.2% of untreated control). …”
  12. 18572
  13. 18573

    FPR1/2/3 expression changes of blood immune cells after 6-month CPAP treatment. by Yung-Che Chen (381913)

    Published 2019
    “…<p>(A) FPR1 (+) percentage on neutrophil was decreased after > 6-month CPAP treatment. …”
  14. 18574
  15. 18575
  16. 18576
  17. 18577

    Analyses of directed phase lag index (dPLI [44]) for excitatory/inhibitory (E/I) ratios with respect to pyramidal (Pyr) and parvalbumin (PV) populations (<i>A</i>) and Pyr and soma... by Nobuhiko Wagatsuma (494052)

    Published 2025
    “…<p>Black circles and gray pentagons represent the mean values of dPLI from PV to Pyr and from SOM to Pyr populations, respectively. …”
  18. 18578
  19. 18579

    Docking results of effective compounds in TFDM. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”
  20. 18580

    Active compounds screened from TFDM. by Xu Hu (23350)

    Published 2023
    “…</p><p>Results</p><p>21 active components were screened, 158 potential drug targets for the prevention and treatment of CIRI were obtained, 53 main targets were further screened in the protein-protein interaction network, and 106 signal pathways, 76 biological processes, 26 cell components and 50 molecular functions were enriched (P<0.05). Through the compound-target-pathway network, the key compounds that play a role in the prevention and treatment of CIRI, such as acacetin, apigenin and other flavonoids, as well as the corresponding key targets and key signal pathways, such as AKT1, SRC and EGFR were obtained. …”